Your Cart is Empty
Topical tranexamic acid is a possible ingredient in melasma care, but clinical findings are mixed and do not establish a permanent cure. Some studies show improvement; others do not demonstrate an advantage over the base formula. The exact preparation and comparison matter.
Our main melasma guide covers the condition and broader care. For TXA’s general identity, see tranexamic acid for skin. This page stays with the topical evidence rather than borrowing results from oral treatment.
In a 2012 split-face trial, 23 women applied 5% TXA and its vehicle to opposite sides of the face for 12 weeks; 21 completed the study. Both sides improved, but TXA did not significantly outperform the vehicle. The TXA side also showed increased erythema.
This is a useful reminder that improvement from baseline is not the same as proof that the highlighted active caused the improvement. The comparison group, accompanying sunscreen and study design all affect interpretation.
A 2019 study analyzed 100 participants using 5% TXA solution or 3% hydroquinone cream for 12 weeks. Both groups improved without a significant difference in the pigmentation outcome.
That is encouraging for the tested TXA preparation, but “no significant difference” is not universal equivalence. Small samples, limited follow-up and different carriers can leave uncertainty. Read TXA versus hydroquinone for the clinical and U.S. regulatory distinctions.
These limitations also explain why percentage alone is an incomplete selection method. A product should be evaluated as the preparation the reader will actually use.
Dermatologists may discuss topical or oral TXA for selected patients, but these are separate clinical decisions. Oral research should not appear in a serum’s evidence list as though it tested topical skincare. Our route guide explains the distinction without providing a self-treatment regimen.
Professional procedures and enhanced-delivery studies also do not recreate ordinary home application. Do not combine a serum with home needling to imitate a clinical study.
The American Academy of Dermatology recommends sun protection and gentle skincare for melasma. Tinted sunscreen with iron oxides can help address visible light as part of that strategy. See the iron-oxide sunscreen guide.
There is little value in repeatedly adding pigment products that your skin cannot tolerate. Use the TXA tolerance guide to assess a reaction, and keep application decisions consistent with the agreed treatment plan.
Ask whether the pattern is melasma, which outcome you are trying to change and how progress will be assessed. Bring the full ingredient list of any proposed cosmetic, along with the products you already use.
During pregnancy or breastfeeding, obtain formula-specific advice. Lack of a retinoid on the label is not proof of established pregnancy safety for the remaining actives.
If topical TXA is appropriate within that plan, the formula-selection guide helps translate evidence into a practical choice. The goal is a manageable, reviewed approach to a persistent condition, not an escalating collection of brightening products.
